Vanguard Group’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $2.09M | Buy |
|
|||||
2023
Q3 | $1.82M | Buy |
|
|||||
2023
Q2 | $1.52M | Hold |
|
|||||
2023
Q1 | $1.06M | Hold |
|
|||||
2022
Q4 | $965K | Buy |
|
|||||
2022
Q3 | $1.12M | Sell |
|
|||||
2022
Q2 | $1.83M | Buy |
|
|||||
2022
Q1 | $1.45M | Buy |
|
|||||
2021
Q4 | $3.9M | Buy |
|
|||||
2021
Q3 | $5.99M | Buy |
|
|||||
2021
Q2 | $1.5M | Buy |
|